Biosynex SA (FR:ALBIO) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Biosynex SA, a leading health diagnostics group, has announced its 2025 financial calendar, starting with the release of its 2024 annual revenue on January 13. The company, known for its rapid tests and molecular biology solutions, continues to expand its presence in 95 countries with a strong focus on innovation in healthcare diagnostics.
For further insights into FR:ALBIO stock, check out TipRanks’ Stock Analysis page.